V600E /VEGFR-2 inhibition, and computational studies (original ) (raw )Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation
Kai-Lun Liu
Scientific Reports, 2019
View PDFchevron_right
Design, synthesis, docking, ADMET and anticancer evaluations of N -alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors
Marwa Alsulaimany
RSC Advances, 2022
View PDFchevron_right
Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone
Prof. Mandava venkata Basaveswara Rao
European Journal of Chemistry, 2016
View PDFchevron_right
Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase
Sobhi M . Gomha
Molecules
View PDFchevron_right
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers
ahmad Obaidullah
Journal of Enzyme Inhibition and Medicinal Chemistry
View PDFchevron_right
Rational design, synthesis and molecular modeling studies of novel anti-oncological alkaloids against melanoma
Siva S Panda
Org. Biomol. Chem., 2015
View PDFchevron_right
Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
Marwa El-Gazzar
Frontiers in Chemistry
View PDFchevron_right
Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors
Dong Li
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right
Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma
Mariusz Jaremko
Frontiers in Chemistry, 2023
View PDFchevron_right
Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies
Mona Ibrahim
Pharmaceuticals
View PDFchevron_right
(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies
Ahmed M Metwaly
Molecules
View PDFchevron_right
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Sami Alzarea
Drug Design, Development and Therapy
View PDFchevron_right
Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity
Kyoko Nakagawa-goto
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Synthesis and molecular docking of novel non-cytotoxic anti-angiogenic sulfonyl coumarin derivatives against hepatocellular carcinoma cells in vitro
Aziza Shalby
Journal of Applied Pharmaceutical Science, 2017
View PDFchevron_right
Synthesis, characterization, molecular docking and in vitro anticancer activity of 3-(4-methoxyphenyl)-5-substituted phenyl-2-pyrazoline-1- carbothioamide
Avik Maji
International Journal of Research in Pharmaceutical Sciences, 2021
View PDFchevron_right
Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel bis(1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile) and bis(1,4-dihydropyrazolo[4',3':5,6]pyrano[2,3-b]pyridine-6-carbonitrile) derivatives
Ahmed Elwahy
Bioorganic chemistry, 2017
View PDFchevron_right
Synthesis, anticancer, and molecular docking studies of pyranone derivatives
Shin Aoki
Medicinal Chemistry Research, 2013
View PDFchevron_right
Hit discovery of 4-amino-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin- 5-yl)benzamide: A novel EGFR inhibitor from a designed small library
Ahmed Elkamhawy
View PDFchevron_right
Molecular – Docking Studies of Potent Anticancer Agent
Sunil Ganatra
Journal of Computer Science & Systems Biology, 2012
View PDFchevron_right
Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies
ahmad Obaidullah
Journal of Enzyme Inhibition and Medicinal Chemistry
View PDFchevron_right
Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies
Seema Zargar
Biomolecules, 2022
View PDFchevron_right
Discovery of novel anticancer candidates based on a combination strategy of synthesis, characterization, biological activity evaluation, consensus docking and molecular modeling
hend hekal
Journal of the Iranian Chemical Society
View PDFchevron_right
Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers
Jean Fotie
Bioorganic Chemistry, 2021
View PDFchevron_right
Design, synthesis and computational study of new benzofuran hybrids as dual PI3K/VEGFR2 inhibitors targeting cancer
Omar El-Khouly
Scientific Reports, 2022
View PDFchevron_right
Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents
Erol Erçağ
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Design, synthesis, in silico toxicity prediction, molecular docking, and evaluation of novel pyrazole derivatives as potential antiproliferative agents
Narendra Chandra
EXCLI journal, 2016
View PDFchevron_right
Rational design of thieno[3,2-b]pyridines as potential new VEGFR-2 inhibitors based on improved docking scores
Hugo Froufe
View PDFchevron_right
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
Dina Bakhotmah
Drug Design, Development and Therapy
View PDFchevron_right
Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers
ahmad Obaidullah
Journal of Enzyme Inhibition and Medicinal Chemistry
View PDFchevron_right